Hikma Pharmaceutical | Attività Correnti



Current Assets Cambiamento Data
Almirall EUR 693.24M 29.14M 2024-06
AstraZeneca USD 26.14B 312M 2025-03
Autolus Therapeutics Ltd 660.93M 589.12M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Fresenius EUR 11.45B 219M 2024-12
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 27.85B 4.16B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.45B 479M 2024-12
Orion EUR 1.08B 67.7M 2025-03
Recordati EUR 1.26B 10.61M 2024-09
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
UCB EUR 4.79B 1.47B 2024-12



Hikma Pharmaceutical Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.